During the past decade, ASL NO. 1 Imperiese conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ASL NO. 1 Imperiese" are "Bladder Cancer" (1 trials), "Colorectal Cancer" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "ASL NO. 1 Imperiese" in a lesser frequency.

Most popular intervention types in "ASL NO. 1 Imperiese" are "Drug" (3 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (2 trials), "cisplatin" (2 trials), "etoposide" (1 trials), "fluorouracil" (1 trials) and "gemcitabine hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "ASL NO. 1 Imperiese" are 3 trials for "All" genders.

Currently, there are NaN active trials in "ASL NO. 1 Imperiese". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in ASL NO. 1 Imperiese, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ASL NO. 1 Imperiese, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

ASL NO. 1 Imperiese has several departments that took part in Clinical trials: "Presidio Ospedaliero - U.O. Cardiologia" - 4 trials